Biotech: Page 40

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Ahn Nyeong: South Korea Emerges

    In just three years, South Korea has been reclassified from an emerging market to a developed market by IMS. This is based on South Korea’s GDP level, as well as a well-established and growing economy, rising income levels, better living conditions, and an improved healthcare system that has led ...

    By Kim Ribbink • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Partnering for Diagnostics

    Molecular diagnostics, one of the fastest growing segments in the diagnostics market, are key enablers in delivering personalized medicine. According to industry consultants, molecular diagnostics are set to become the dominant platform in clinical medicine. But currently only about 10% of labels...

    By Denise Myshko • April 25, 2011
  • drug shopping cart Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Creating a Personalized Medicine Strategy

    Considered broadly, healthcare is personal. The goal of medical practitioners has always been to get the right drug to the right person at the right time at the right dose. But now industry experts say personalized medicine is at a tipping point as a multitude of factors converge, including advan...

    By Denise Myshko • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    John Gargiulo, Daiichi Sankyo’s new President and CEO, discusses the future opportunities for the company and the industry. Keeping the Patient Front and Center Last Word PV: What are your goals for Daiichi Sanyko? Gargiulo: The healthcare industry is currently experiencing unprecedented challeng...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    America’s biopharmaceutical ­research companies invested a record $67.4 billion last year in R&D, an increase of $1.5 billion. Healthcare Providers Say Pharma Provides Value Almost 8 out of 10 physicians view pharmaceutical companies and their sales reps as useful sources of information on ­m...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The mHealth Revolution The Statistics are staggering. According to a report by research2guidance, by 2015 one in five people around the world will have a smartphone. Another report states that mobile app revenue is expected to reach $35 billion by 2014. Finally, company investment in mobile phone...

    By Taren Grom • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Era of Biosimilars

    Although healthcare reform paved the way for a regulatory pathway for biosimilars, the ­biopharmaceutical industry is facing a world of uncertainty as developers and regulators ­navigate their way through this shifting ­landscape. Biosimilar Defined » A “biosimilar" is a biological product that i...

    By Denise Myshko • March 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Privyet! Russia: Growth and Opportunity

    With its promise of expansion, its population of around 140 million potential customers, and a pool of highly qualified staff, Russia has long been recognized as an important market for pharmaceutical companies. The pharma market in Russia has shown stable annual growth of 13% to 20% for several ...

    By Kim Ribbink • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Steve FRY Dr. Sue MAHONY Lilly Announces Leadership Shifts Lilly has promoted Steve Fry to senior VP of human resources and diversity. Mr. Fry was previously VP of human resources for two of Lilly’s business areas, biomedicines and emerging markets. Mr. Fry succeeds Sue Mahony...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    » Scott Weintraub Honored Scott Weintraub, founding ­principle of Healthcare ­Regional Marketing, has been selected for the 2010 ­Outstanding Leadership ­Recognition Award by the U.S. ­Leaders and Entrepreneur’s ­Association (USLEA). The USLEA Awards Program recognizes highly regarded individuals...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The Price of Success THE COST OF INNOVATION. The recent article published in the Feb. 7, 2011, issue of the journal BioSocieties for The London School of Economics and Political Science is causing quite a stir. The authors — Donald W. Light of Stanford University and University of Medicine and De...

    By Taren Grom • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Thought Leaders

    Ryan Abbate. President, Pacific ­Communications, a healthcare communications agency that ­offers strategic and tactical communications solutions. For more information, visit ­ ­pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized ­Medicine Coalition, which brings together the academ...

    By PharmaVoice Team • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Technology at the Speed of Light

    The impact that the Internet and follow-on technologies have had on all areas of the life-sciences is well-documented throughout this special section, and the majority of our thought leaders have identified this as the biggest game changer in the last 10 years. Going even further, these same thou...

    By PharmaVoice Team • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Robert CUDDIHY Sanofi-Aventis Adds to Diabetes Team Sanofi-Aventis U.S. has appointed Robert Cuddihy, M.D., VP, medical diabetes head in the U.S. Dr. Cuddihy is responsible for developing and executing the U.S. medical affairs strategy for Sanofi-Aventis’s diabetes divisio...

    By PharmaVoice Team • March 3, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Through its recent acquisition of MedPage Today, a news organization serving healthcare professionals, Everyday Health has added a significant offering for healthcare professionals to its portfolio of consumer health information brands. MedPage provides healthcare professionals with peer-reviewed...

    By PharmaVoice Team • March 3, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Digital Marketing: Dare to be Different

    Research shows creativity is one of the most important components of a successful campaign, however, our experts say there are several other elements behind a campaign that need to be present to make the best of what digital media have to offer. Among them are matching the audience with the most ...

    By PharmaVoice Team • Jan. 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Robert DAVIS Dr. Ludwig HANTSON Baxter International Forms Medical Products Business Baxter International has appointed Robert Davis corporate VP and president of its newly created medical products business, which combines the company’s renal and medication delivery businesses...

    By PharmaVoice Team • Jan. 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Awards… Cephalon wins PRSA Awards CRF Health Wins at Clio Natrel Wins Rx Club Award INDUSTRY at Large Smarty Apps… E-Promotion on the E-Rise Supporting Science Education Lucky 14 Pharma Saves Green by Going Green Disruptive Technology, Disruptive times Top Innovators Podcasts Best Practices for Y...

    By PharmaVoice Team • Jan. 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Emerging Market: Ola Brazil

    With every passing year, the pharmaceutical industry becomes more global in its ­ outlook and reach. In recognition of our shrinking world, PharmaVOICE is taking you on a journey across the globe. Our first stop is Latin America’s largest market, Brazil. Brazil is familiar territory to the pharma...

    By Kim Ribbink • Dec. 27, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Biotech: Raising Capital in a Tight Market

    The global financial crisis has made it challenging for the biotechnology industry to raise capital to fund innovation. Experts say venture capital money is still available, but often the VC community is looking for lower-risk, short-term projects. As a result, biotech companies are increasingly ...

    By Denise Myshko • Dec. 27, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Achieving Global Launch Excellence

    The details of what comprise a global launch vary depending upon who is doing the defining, but experts can agree that the launch environment is becoming more challenging. And with the value of the global pharmaceutical market expected to grow 5% to 7% in 2011, according to IMS Health, the incent...

    By PharmaVoice Team • Dec. 27, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Genome: The Next 10 Years

    In just one generation medicine will take a huge leap forward. That is, if researchers are right about how data from the human genome can be used to address disease. There has been a great deal of optimism about how sequencing the human genome might create new diagnostics and new medicines. Ten y...

    By Denise Myshko • Dec. 27, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Pharma Forecast Simon King, a pharmaceutical company analyst at ­Datamonitor, comments on trends expected to impact “big pharma" in 2011. PV: Despite a challenging year for Roche, you say restructuring will help the company maintain a strong fiscal position. What other factors do you think will h...

    By PharmaVoice Team • Dec. 27, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Milind DESHPANDE Achillion Pharmaceuticals Promotes R&D President Achillion Pharmaceuticals, which is focused on the discovery and development of small-molecule drugs to combat challenging infectious diseases, has promoted Chief Scientific Officer Milind Deshpande, Ph....

    By PharmaVoice Team • Dec. 27, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: New Solutions Help Harness Social Monitoring Insights CRM Update In Other Technology News… AstraZeneca BioClinica Chiltern International Cmed Technology Decision Resources PharmaVigilant E-Upgrades and Enhancement...

    By PharmaVoice Team • Dec. 27, 2010